Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2022 | 02-2022 | 11-2021 | 08-2021 | 05-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,533 | 78,780 | 80,506 | 147,440 | 188,207 |
| Marketable Securities | 255,746 | 183,198 | 215,214 | 196,458 | 197,814 |
| Receivables | N/A | 6,204 | 6,204 | 204 | 5,679 |
| Other current assets | 0 | 2,000 | 0 | 5,000 | 0 |
| TOTAL | $306,789 | $280,484 | $311,118 | $358,445 | $396,281 |
| Non-Current Assets | |||||
| PPE Net | 15,507 | 13,522 | 11,340 | 9,569 | 8,345 |
| Investments And Advances | 51,538 | 123,685 | 137,189 | 121,480 | 110,440 |
| Other Non-Current Assets | 20,476 | 20,029 | 17,124 | 3,580 | 2,915 |
| TOTAL | $87,521 | $157,236 | $165,653 | $134,629 | $121,700 |
| Total Assets | $394,310 | $437,720 | $476,771 | $493,074 | $517,981 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,142 | 6,014 | 6,650 | 3,861 | 5,405 |
| Accrued Expenses | 19,734 | 11,419 | 14,549 | 11,569 | 7,678 |
| TOTAL | $72,665 | $66,049 | $66,258 | $50,680 | $46,844 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 41,319 | 43,186 | 41,212 | 35,250 | 33,761 |
| Other Non-Current Liabilities | 9,043 | 10,326 | 9,189 | 796 | 837 |
| TOTAL | $54,906 | $65,754 | $68,211 | $67,177 | $72,959 |
| Total Liabilities | $127,571 | $131,803 | $134,469 | $117,857 | $119,803 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,042 | 44,950 | 44,738 | 44,613 | 44,427 |
| Common Shares | 45 | 45 | 45 | 45 | 44 |
| Retained earnings | -308,826 | -263,425 | -220,892 | -183,190 | -154,355 |
| Other shareholders' equity | -3,085 | -2,066 | -608 | -59 | 30 |
| TOTAL | $266,739 | $305,917 | $342,302 | $375,217 | $398,178 |
| Total Liabilities And Equity | $394,310 | $437,720 | $476,771 | $493,074 | $517,981 |